Clinical trial
A Pilot Study of Danirixin for Disease Progression in Chronic Obstructive Pulmonary Disease (COPD)
NCT03170232
Study timeline
Study start (actual)2017-10-16Date precision: day
Registry last updated2020-07-31
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Pulmonary Disease, Chronic Obstructiveunresolved
Interventions
Sponsors & collaborators
GlaxoSmithKlinelead sponsor
Mapped research locations
HoustonTexas, United States1PhiladelphiaPennsylvania, United States1BaltimoreMaryland, United States1PittsburghPennsylvania, United States1BirminghamAlabama, United States1San DiegoCalifornia, United States1DenverColorado, United States1Ann ArborMichigan, United States1Iowa CityIowa, United States1TorranceCalifornia, United States1Saint PaulMinnesota, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03170232 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.